指南与共识泌尿男性生殖肿瘤

转移性去势抵抗性前列腺癌的系统治疗:ASCO动态指南2026.1.4版

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.
指南 / 共识 · J Clin Oncol · 2026-08-06

该文为ASCO针对转移性去势抵抗性前列腺癌系统治疗制定的动态指南2026.1.4版的方法学说明。动态指南由常设专家小组持续系统检索文献并定期更新,遵循ASCO指南方法学手册和利益冲突政策,不替代临床医生的独立专业判断,也不考虑患者个体差异。

要点

  • ASCO动态指南由常设专家小组持续系统检索文献并定期更新推荐。
  • 该指南针对转移性去势抵抗性前列腺癌的系统治疗。
  • 指南不替代临床医生独立判断,也不考虑患者个体差异。

核心结论

  • ASCO针对转移性去势抵抗性前列腺癌系统治疗发布动态指南2026.1.4版,由常设专家小组持续更新。

研究设计与样本

  • 动态指南由常设专家小组持续系统检索健康文献,按ASCO指南方法学手册定期更新。

临床怎么用

  • 临床医生可参考该动态指南获取转移性去势抵抗性前列腺癌系统治疗的更新推荐。
  • 使用指南时需结合独立专业判断,并考虑患者个体差异。

局限性

  • 动态指南不替代治疗临床医生的独立专业判断,也不考虑患者个体差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

[Box: see text]Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only). Updates are published regularly and can be found on the ASCO Publications website.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Taplin ME, Parikh RA, Rumble RB, et al. Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4. J Clin Oncol. 2026. PMID: 42561262. doi:10.1200/JCO-26-01898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。